To test our hypothesis, we firstly analyzed the survival curves of the glioma patients with high or low KLF9 expression from TCGA database, and found that patients with high KLF9 expression survived longer than patients in the other group (Fig. 6A). This evidence concerns the gene KLF9 and central nervous system cancer.